Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT02217046 Recruiting - Infection Clinical Trials

Decrease Implantation Site INFECTION : a Randomized Controlled Trial

Start date: December 2013
Phase: N/A
Study type: Interventional

Cardiovascular implantable electronic device (CIED) infections have been increasing out of proportion to the number of devices implanted the investigators investigated recent trends and possible causes of the increasing numbers of Cardiovascular implantable electronic device infections.

NCT ID: NCT02196753 Recruiting - Complications Clinical Trials

PET CT in Suspected CIED Infection, a Pilot Study - PET Guidance I

PET Guidance I
Start date: March 2014
Phase: N/A
Study type: Observational

The aim of this single-center randomized controlled trial is to assess clinical usefulness of positron emission tomography combined with computed tomography (PET CT) in the diagnostic process of suspected cardiovascular implantable electronic device (CIED) infection (lead dependent infective endocarditis, generator pocket infection, fever of unknown origin).

NCT ID: NCT02191475 Recruiting - Abdominal Infection Clinical Trials

Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock

Tigecycline
Start date: May 2014
Phase: Phase 2/Phase 3
Study type: Interventional

Selection of tigecycline in severe sepsis and septic shock patients in empirical antibiotic therapy (Hai Zheng Energy Star ®) combined with piperacillin / tazobactam (tazocin ®) scheme, compared with the classical scheme, evaluate its efficacy, safety index.

NCT ID: NCT02172833 Recruiting - Infection Clinical Trials

Antibiotic-associated Coagulopathy

Start date: January 2014
Phase: N/A
Study type: Observational

Over the past few decades, a good number of studies with regard to coagulopathy and increased bleeding tendency which is defined as macro- or microscopic hemorrhage, declination of hemoglobin level, thrombocytopenia, and hypoprothrombinemia potentially caused by the use of antibiotics through a variety of suggested mechanisms, including myelosuppression, immune-mediated destruction of thrombocytes and coagulation factors, and suppression of vitamin K epoxide reductase or vitamin K-dependent γ-glutamate carboxylase which may lead to inhibition of biosynthesis of coagulation factor II, VII, IX, and X, have been reported or published. Nevertheless, many of them are case-series studies or case reports with low level of evidence, and there have been no large-scale retrospective cohort studies regarding antibiotic-associated coagulopathy being published. Moreover, in addition to exposure to antibiotics, there are several risk factors, including severity of illness, hepatic or renal function, nutrition status, comorbidities such as cancer and hematologic disease, surgery or other invasive procedure, concomitant use of anticoagulants, NSAIDs, and salicylates, and age, which may exert influence on the function of the coagulation system as well. Therefore, the study aims to clarify the association between the use of antibiotics and the increase of bleeding tendency or the development of bleeding event and to identify possible risk factors of the increase of bleeding tendency or the development of bleeding event in patients receiving antibiotic treatment through the application of nested case-control design and the usage of both the National Health Insurance Research Database (NHIRD) and medical records in National Taiwan University Hospital during the time period from January, 1995 to December, 2013.

NCT ID: NCT02162966 Recruiting - Infectious Diseases Clinical Trials

Safety and Efficacy Study of High Dose Colistin

Start date: May 2014
Phase: Phase 4
Study type: Interventional

Colistin is a rapidly acting bactericidal antimicrobial agent that possesses a post antibiotic effect against MDRO Gram-negative bacteria, such as as Pseudomonas aeruginosa, Acinetobacterbaumannii, and Klebsiella pneumonia.

NCT ID: NCT02158442 Recruiting - Diabetes Clinical Trials

Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients

Start date: October 2013
Phase: Phase 2
Study type: Interventional

The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life.

NCT ID: NCT02143336 Recruiting - Colorectal Surgery Clinical Trials

Subcuticular Continuous Suture Versus Skin Staples to Reduce Surgical Site Infections in Colorectal Surgery Patients

Start date: September 2013
Phase: N/A
Study type: Interventional

A comparison of skin closure techniques (standard skin closure with staples versus a continuous (subcuticular) absorbable suture), to determine if this changes the rate of post operative wound infections in elective colorectal surgery patients.

NCT ID: NCT02140853 Recruiting - Infection Clinical Trials

MDR Bacilli Surveillance and Clinical Feature in China

MDR
Start date: November 2011
Phase: N/A
Study type: Observational

Objective 1. To evaluate the impact of MDR pathogen on prognosis and therapy cost; 2. To compare the efficacy of different antibiotics in treatment of infection caused by MDR pathogens; 3. To evaluate the risk factors of MDR pathogens infection; 4. To evaluate the distribution and characteristics of MDR pathogens; 5. To investigate the proportion of MDR isolates to construct systematic database.

NCT ID: NCT02129465 Recruiting - Pregnancy Clinical Trials

Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy

CMV
Start date: June 2014
Phase: N/A
Study type: Observational

Analysis of several characteristics of blood from pregnant women with CMV infection according to maternal-fetal transmission. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.

NCT ID: NCT02123771 Recruiting - Clinical trials for HELICOBACTER PYLORI INFECTIONS

Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections

Start date: May 2013
Phase: Phase 1
Study type: Observational

The investigators hypothesis: Presence of anti-GGT (antibody against GGT) indicates H. pylori infection.